CONMED Corp. Stock
CONMED Corp. Stock
A very strong showing by CONMED Corp. today, with an increase of €1.00 (3.210%) compared to yesterday's price.
Our community is currently high on CONMED Corp. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 59 € shows a very positive potential of 83.23% compared to the current price of 32.2 € for CONMED Corp..
Pros and Cons of CONMED Corp. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | 3.210% | -8.000% | -8.000% | -52.647% | -8.000% | -63.200% | -65.000% |
| Bio-Rad Labs Inc. A | -0.120% | -7.052% | -3.916% | -27.607% | -3.916% | -42.466% | -49.634% |
| Neogen Corp. | -1.720% | 4.217% | 40.650% | -22.072% | 40.650% | - | - |
| Icu Medical Inc. | -0.800% | -3.876% | 0.000% | -21.019% | 0.000% | -29.545% | -25.749% |
Comments
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $91.00 to $61.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat